企業大事記 Business History


幸一生醫集團 
台灣OTC&藥妝市場 專業的婦幼領導品牌
Professional Leading Brands in Women and Children Healthcare in OCT& cosmeceutical marekt in Taiwan

1961 日本理研製藥化學工業株式會社授權幸一生醫集團之辰太實業有限公司在台灣銷售【利撒爾リサ一ル 兒童感冒 藥至今近60年。
Riken Chemical Co., Ltd. of Japan authorized Taiwan Chentai Industry Co., Ltd. of Shinyi Biomedical to sell RISAL cold medicine for                    children in Taiwan, and the latter has sold it for nearly 60 years by now.

1975 集團大亞藥品工業有限公司成立,負責OTC藥品生產
The group established Daya Pharmaceutical Co., Ltd. to produce OTC medicines.

1983 大亞藥廠醫藥研發團隊與美國Sausley藥廠合作推出婦潔液,成功以電視廣告行銷台灣
Daya Pharmaceutical’s pharmaceutical R&D team cooperated with Sausley pharmaceutical factory of the United States to release a feminine wash and succeeded in marketing It via TV commercials in Taiwan.

2000 幸一生醫科技有限公司成立,主要承接辰太公司利撒爾與大亞藥品公司婦潔兩個品牌之市場營銷。
Shinyi Biomedical Technology Co., Ltd. was established and mainly engaged in the marketing of Chentai’s RISAL and Daya’s Vigill.

2005 婦潔藥品有限公司成立,主要專注負責婦潔液系列產品之研發與生產製造。
The group established Vigill Pharmaceutical Co., Ltd., which is mainly engaged in the research, development, and production of Vigill feminine wash series

2010 婦潔藥品公司與以色列國際領導藥廠合作,開發亞洲女性專用【婦潔VIGILL日常私密保養系列】。
 
Vigill Pharmaceutical Co. cooperated with an international leading Israeli pharmaceutical manufacturer in development of VIGILL daily intimate care series for Asian women.

2011 幸一生醫科技有限公司與日本技術合作,在台灣上市推出【小兒利撒爾 健康補給站】兒童專業保健食品與機能性食品。
Co-operating with Riken Chemical Co., Ltd. of Japan, Shinyi Biomedi lauched RISAL Kids' food supplement range in Taiwan market. 

2017 婦潔藥品推出女性私密保健食品系列,內服外用全方位滿足女性私密健康護理需求。
Shinyi released the women’s intimate care dietary supplement series to meet women’s need of intimate care products for internal and external use.
  
2019 
幸一生醫集團上海運營中心上海一騰商貿有限公司正式進駐上海虹橋商務區
  
Shinyi Biomedical Co. established Shanghai A Teng Co., Ltd. as its Shanghai operation center at Shanghai Hongqiao Business Zone.

2020 幸一生醫科技有限公司分別與香港Full Asia Enterprises Ltd. 和馬來西亞 GK Bio International Sdn. Bhd. 合作經營香港與馬來西亞、新加坡、汶萊市場。
  
Shinyi Biomedical Co. co-operated with Hong Kong Full Asia Enterprises Ltd and Malysian GK Bio International Sdn. Bhd. in Hong Kong, Malaysia, Singapore, Brunei Markets.